Target intelligence / Profile preview

Urea transporter 2 (UT-A2) (UT-A2)

Target
UT-A2
Molecular classification
Transporter, Solute carrier family, Urea transporter family
01

Overview

Urea transporter 2 (UT-A2) is a transmembrane protein encoded by the SLC14A2 gene, primarily expressed in the thin descending limb of the loop of Henle within the kidney [1][2]. It facilitates the passive transport of urea, which is a critical component of the intrarenal urea recycling process [2]. This recycling is essential for establishing and maintaining the high osmotic gradient in the inner medulla, which allows for efficient water reabsorption and the production of concentrated urine [3]. From a therapeutic perspective, UT-A2 is considered a promising target for "urearetic" diuretics [4]. Unlike traditional diuretics that target sodium transporters and often cause electrolyte imbalances, UT-A2 inhibitors promote water excretion by disrupting the medullary osmotic gradient [4][5]. Research into small-molecule inhibitors of UT-A2 is currently focused on treating fluid overload states associated with congestive heart failure, cirrhosis, and nephrotic syndrome [5]. These inhibitors aim to provide a more balanced diuretic effect with fewer side effects related to potassium or sodium loss [4]. Sources: [1] UniProt (Q15848); [2] Sands, J. M. (2003) Annu. Rev. Physiol.; [3] Klein, J. D., & Sands, J. M. (2011) Urea Transporters; [4] Esteva-Font, C., et al. (2014) Curr. Med. Chem.; [5] Verkman, A. S., et al. (2014) Nat. Rev. Nephrol.

Other names
SLC14A2Urea transporter ASolute carrier family 14 member 2HUT11UT-A
02

Mechanism of action

Inhibition of urea transport in the thin descending limb of Henle's loop, which disrupts the medullary osmotic gradient and reduces the kidney's ability to concentrate urine, resulting in increased water and urea excretion.

03

Biological functions

Urea transportUrinary concentrationOsmoregulationRenal water reabsorptionMedullary osmotic gradient maintenance
04

Disease associations

HypertensionEdemaCongestive heart failureCirrhosisNephrotic syndrome
05

Safety considerations

DehydrationHypernatremiaPotential for urea accumulation in non-renal tissues
06

Interacting drugs

Thiourea

3 more in the full profile.

07

Biomarkers

Urine osmolalityUrinary urea concentrationFractional excretion of urea

Beyond the preview

Go deeper on Urea transporter 2 (UT-A2) (UT-A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea transporter 2 (UT-A2) (UT-A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call